ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

COV Cleo Diagnostics Ltd

0.385
0.045 (13.24%)
Jun 14 2024 - Closed
Delayed by 20 minutes

Cleo Diagnostics Financial Summary

The current COV market cap is 28.53M. The company's latest EPS is AUD -0.0233 and P/E is -16.31.

Year End June 29 2023 20222023
AUD (AUD)AUD (AUD)
Total Revenue 0110k
Operating Income -43k-1.62M
Net Income -44k-1.73M
Year End June 29 2023 20222023
AUD (AUD)AUD (AUD)
Total Assets 244k1.08M
Total Liabilities 286k2.02M
Total Equity -42k-943k

Cash Flow

Year End June 29 2023 20222023
AUD (AUD)AUD (AUD)
Operating N/A -684k
Investing -200k-340k
Financing 242k1.22M
Market Cap 28.53M
Price to Earnings Ratio -16.31
Price to Sales Ratio 253.33
Price to Cash Ratio 118.75
Price to Book Ratio -29.86
Dividend Yield -

Share Statistics

Shares Outstanding 74.1M
Average Volume (1 week) 459.35k
Average Volume (1 Month) 557.27k
52 Week Change 67.39%
52 Week High 0.395
52 Week Low 0.14
Spread (Intraday) 0.03 (7.69%)

Company Info

Company Name Cleo Diagnostics Ltd
Address level 2, 480 collins street, melbourne vic 3000
melbourne, victoria 3000
Website https://cleodx.com
Industry gen med & surgical hospitals (8062)

Your Recent History

Delayed Upgrade Clock